Fresenius SE & Co. KGaA (LON:0OO9)

London flag London · Delayed Price · Currency is GBP · Price in EUR
50.38
+0.22 (0.44%)
At close: Feb 12, 2026
Market Cap24.57B +40.2%
Revenue (ttm)19.59B +4.5%
Net Income997.68M
EPS1.77
Shares Outn/a
PE Ratio24.63
Forward PE13.44
Dividend0.84 (1.67%)
Ex-Dividend DateMay 26, 2025
Volume41,867
Average Volume271,860
Open50.38
Previous Close50.16
Day's Range49.95 - 50.62
52-Week Range31.99 - 51.98
Beta0.90
RSI57.77
Earnings DateFeb 25, 2026

About Fresenius SE & Co. KGaA

Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients. It operates through Fresenius Kabi and Fresenius Helios segment. The Fresenius Kabi segment engages in the therapy and care of critically and chronically ill patients; enteral and parenteral nutrition products; medical technologies, as well as disposables, infusions pumps, apheresis machines, cell therapy devices, and other products. The Fresenius Helios segment provides clinical and nursing care facilities. The company was formerly know... [Read more]

Industry Miscellaneous Health And Allied Services, Not Elsewhere Classified
Founded 1912
Employees 177,356
Stock Exchange London Stock Exchange
Ticker Symbol 0OO9
Full Company Profile

Financial Performance

Financial numbers in EUR Financial Statements